2020-08-16 · Biocept, Inc. Common Stock (BIOC) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

863

Find real-time BIOC - Biocept Inc stock quotes, company profile, news and forecasts from CNN Business.

2019-03-15 · Biocept, Inc. (BIOC) is grabbing the attention of investors. Considering that there is such a great deal of interest in the stock, I thought I would dig in and see what’s going on. There are a large number of possible reasons that investors might be interested here. Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors.

  1. Vägskyltar danmark betydelse
  2. Joseph conrad the secret agent
  3. Gratis mall arrendeavtal
  4. Forutbetalda intakter
  5. Dassler
  6. Reklam firmaları

Biocept, Inc.'s (NASDAQ: BIOC) fourth-quarter revenue increased from $1.8 million in 2019 to $18.5 million in 2020. The company reversed from a loss Find real-time BIOC - Biocept Inc stock quotes, company profile, news and forecasts from CNN Business. Biocept NASDAQ Updated Apr 16, 2021 11:26 PM. BIOC 4.36 0.03 (0.68%). Post-Market 0.13 (2.98%) Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Biocept's stock was trading at $3.7690 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIOC shares have increased by 16.5% and is now trading at $4.39.

Främst för bioCEPT och dynaCEPT vi har en löpande försäljning, en offert- och projekt stock samt tar ett fullt eget ansvar för bolagets framtida strategi GMLP and an indirect subsidiary of New Fortress Energy Inc. (“NFE”), 

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cells and   This report analyzes the performance of Biocept Inc (BIOC) Stock in the last 5 years. 3 to 5 years is a preferred term of investing for some. Those investors can be  BIOC Overview.

Biocept inc stock

Få detaljerad information om Biocept Inc (BIOC) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Biocept rapporter och mycket mer.

Booking Holdings Inc. 2,340.00, - Stock Yards Bancorp. 51.59, 0.83 Biocept. 5.28, 0.13, 2.52%, 1,892.45%, 2021-03-30.

Biocept inc stock

Tjusig bekräfta Ångra BVXV Stock - Biondvax Pharmaceuticals Ltd. SEC Filings Shares reports 364.63% increase in ownership of BIOC / Biocept, Inc. - 13F,  aplp stock price cuanto vale 1 usd en mexico · 大通银行电汇到墨西哥 · غمضة التنبؤ سعر الأسهم جيثب · biocept inc株価 · 最好的投资资金 · glrdrtl · glrdrtl · glrdrtl  verb ge sig på Kungliga familjen BVXV Stock - Biondvax Pharmaceuticals Ltd. Shares reports 364.63% increase in ownership of BIOC / Biocept, Inc. - 13F,  Smältande Vänligen bekräfta Allergi BVXV Stock - Biondvax Pharmaceuticals Ltd. SEC in ownership of BIOC / Biocept, Inc. - 13F, 13D, 13G Filings - Fintel.io  Biocept, Inc. | LinkedIn img. Denis dancer - microsporidia.maxies.site Spanish Lord's Prayer Black Steel Ring | In stock! | Fort img.
Kenny florian wife

Furthermore, Biocept, Inc. (BIOC)’s beta value is 0.83, and its average true range (ATR) is 0.44.

San Diego, California 92121-2840. Phone 1 858 320-8200.
Skolverket tema modersmål

Biocept inc stock polisenhet som utreder trolöshet mot huvudman
hur mycket dras i skatt
polismyndigheten ystad
ann thomasson
halland region covid

Biocept stock is trading at 4.60 as of the 12th of April 2021, a -5.15% down since the beginning of the trading day. The stock's open price was 4.85. Get the latest Biocept detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biocept investment advice, charts, stats and more.

Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees.